MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
80.39
-1.74
-2.12%
After Hours: 80.39 0 0.00% 17:56 12/12 EST
OPEN
82.32
PREV CLOSE
82.13
HIGH
83.00
LOW
79.98
VOLUME
426.40K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
52.50
MARKET CAP
1.81B
P/E (TTM)
49.30
1D
5D
1M
3M
1Y
5Y
1D
ANI Pharmaceuticals Sr. VP Meredith Cook Reports Sale of Common Shares
Reuters · 2d ago
GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea
NASDAQ · 2d ago
GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer
NASDAQ · 3d ago
Roche's Breast Cancer Drug Cuts Risk of Death by 30% in Phase III
NASDAQ · 3d ago
Implied Volatility Surging for ANI Pharmaceuticals Stock Options
NASDAQ · 3d ago
Director Makes Strategic Move with ANI Pharmaceuticals Stock Sale
TipRanks · 5d ago
Barclays Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)
TipRanks · 5d ago
Director Renee P. Tannenbaum Reports Sale of ANI Pharmaceuticals Inc. Common Shares
Reuters · 5d ago
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.